Masatoshi Kudo Selected Research

Masatoshi Kudo Research Topics

Disease

443	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 11/2001
196	Neoplasms (Cancer) 02/2024 - 11/2001
58	Liver Neoplasms (Liver Cancer) 05/2024 - 01/2003
32	Neoplasm Metastasis (Metastasis) 07/2022 - 11/2001
29	Fibrosis (Cirrhosis) 12/2022 - 12/2005
27	Inflammation (Inflammations) 04/2024 - 10/2002
27	Infections 12/2022 - 01/2004
25	Liver Diseases (Liver Disease) 12/2022 - 01/2003
25	Chronic Hepatitis C 08/2019 - 01/2002
22	Hypertension (High Blood Pressure) 04/2024 - 10/2013
20	Disease Progression 11/2023 - 01/2011
18	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2006
17	Ulcerative Colitis 03/2024 - 11/2006
16	Autoimmune Pancreatitis 03/2024 - 02/2010
16	Fatigue 08/2023 - 09/2013
16	Immunoglobulin G4-Related Disease 12/2022 - 03/2012
15	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019 - 10/2005
13	Hepatitis C 04/2024 - 12/2006
13	Hepatitis B 04/2024 - 10/2006
13	Hepatitis 01/2023 - 01/2003
12	Pancreatitis 01/2024 - 01/2009
12	Ascites 02/2023 - 02/2006
12	Hemorrhage 01/2023 - 02/2002
11	Chronic Hepatitis B 12/2022 - 01/2011
11	Chronic Hepatitis (Chronic Active Hepatitis) 01/2011 - 01/2002
9	Colitis 03/2024 - 01/2019
9	Thrombosis (Thrombus) 08/2023 - 01/2003
9	Necrosis 04/2022 - 07/2010
9	Carcinogenesis 01/2019 - 01/2011
8	Cholangitis 10/2022 - 01/2011
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2023 - 01/2015
7	Pathologic Constriction (Stenosis) 10/2022 - 11/2016
7	Thrombocytopenia (Thrombopenia) 02/2019 - 12/2010
6	Crohn Disease (Crohn's Disease) 03/2024 - 01/2017
6	COVID-19 03/2024 - 09/2020
6	Adenocarcinoma 11/2023 - 01/2004
6	Non-alcoholic Fatty Liver Disease 08/2023 - 09/2016
6	Diarrhea 06/2023 - 01/2016
6	Ulcer 08/2020 - 09/2009

Drug/Important Bio-Agent (IBA)

109	Sorafenib (BAY 43-9006)FDA Link 12/2023 - 06/2010
57	lenvatinibIBA 04/2024 - 01/2017
46	Bevacizumab (Avastin)FDA Link 05/2024 - 01/2019
45	atezolizumabIBA 05/2024 - 01/2020
43	InterferonsIBA 12/2022 - 01/2002
42	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2016
33	Biomarkers (Surrogate Marker)IBA 08/2023 - 11/2006
25	BilirubinIBA 05/2024 - 02/2006
25	RamucirumabIBA 07/2022 - 07/2015
23	AlbuminsIBA 05/2024 - 01/2011
23	CytokinesIBA 04/2024 - 11/2006
23	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 12/2006
23	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2002
21	Immunoglobulin G (IgG)IBA 12/2022 - 02/2010
19	gadolinium ethoxybenzyl DTPA FDA Link 12/2023 - 01/2009
19	SonazoidIBA 01/2021 - 01/2008
19	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2008
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022 - 07/2010
15	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2011
14	pembrolizumabIBA 12/2023 - 01/2017
13	LigandsIBA 11/2023 - 03/2012
13	Contrast MediaIBA 04/2017 - 11/2001
12	acarboxyprothrombin (PIVKA)IBA 04/2024 - 12/2006
12	NivolumabIBA 01/2024 - 01/2017
12	Tumor Biomarkers (Tumor Markers)IBA 10/2019 - 10/2005
11	AntigensIBA 04/2023 - 01/2008
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 10/2006
11	Interleukin-33IBA 05/2021 - 01/2017
10	Fetal Proteins (Fetoprotein)IBA 05/2024 - 09/2007
10	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 12/2010
10	NucleotidesIBA 11/2023 - 10/2002
9	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2011
9	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2011
8	Alanine Transaminase (SGPT)IBA 04/2024 - 01/2008
8	SteroidsIBA 01/2024 - 09/2008
8	entecavir FDA Link 12/2022 - 08/2011
8	GadoliniumIBA 11/2021 - 01/2011
8	Coloring Agents (Dyes)IBA 01/2020 - 12/2002
8	SHU 508 (Levovist)IBA 07/2010 - 11/2001
7	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023 - 03/2012
7	regorafenibIBA 06/2023 - 01/2016
7	CateninsIBA 04/2023 - 05/2014
7	EnzymesIBA 10/2022 - 10/2011
7	Serum AlbuminIBA 08/2021 - 02/2006
7	RNA (Ribonucleic Acid)IBA 01/2017 - 01/2002
6	Prednisolone (Predate)FDA LinkGeneric 04/2024 - 07/2020
6	tremelimumabIBA 12/2023 - 01/2021
6	durvalumabIBA 12/2023 - 01/2021
6	cabozantinibIBA 06/2023 - 05/2018
6	Pentetic Acid (DTPA)FDA LinkGeneric 01/2017 - 04/2011

Therapy/Procedure

228	Therapeutics 05/2024 - 01/2002
66	Radiofrequency Ablation 10/2023 - 01/2003
31	Drug Therapy (Chemotherapy) 04/2024 - 01/2009
28	Immunotherapy 02/2024 - 03/2018
17	Stents 09/2023 - 01/2011
13	Aftercare (After-Treatment) 10/2022 - 03/2003
12	Hepatectomy 10/2023 - 03/2002
11	Molecular Targeted Therapy 09/2019 - 01/2008
9	Microbubbles 05/2010 - 11/2001
8	Surgical Instruments (Clip) 06/2021 - 01/2003
6	Electrodes (Electrode) 10/2016 - 07/2004